<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id><journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id><journal-id journal-id-type="publisher-id">CMJ</journal-id><journal-title-group><journal-title>Chinese Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0366-6999</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26168831</article-id><article-id pub-id-type="pmc">4717933</article-id><article-id pub-id-type="publisher-id">CMJ-128-1905</article-id><article-id pub-id-type="doi">10.4103/0366-6999.160526</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Changes of Serotonin (5-HT), 5-HT2A Receptor, and 5-HT Transporter in the Sprague-Dawley Rats of Depression, Myocardial Infarction and Myocardial Infarction Co-exist with Depression</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Mei-Yan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/><xref ref-type="author-notes" rid="fn1"/></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Yan-Ping</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="author-notes" rid="fn1"/></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Wan-Lin</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Guo-Xiang</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Guo</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China</aff><aff id="aff2"><label>2</label>Department of Geriatric-cardiovascular, First Affiliated Hospital of Medical College, Xi&#x02019;an, Shaanxi 710061, China</aff><aff id="aff3"><label>3</label>Department of Cardiology, Military General Hospital of Beijing PLA, Beijing 100700, China</aff><aff id="aff4"><label>4</label>Department of 4<sup>th</sup> Cadres Ward, Military General Hospital of Beijing PLA, Beijing 100700, China</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Mei-Yan Liu, Department of Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China E-Mail: <email xlink:href="zhanglijun0411@126.com">zhanglijun0411@126.com</email></corresp><fn id="fn1"><p>Mei-Yan Liu and Yan-Ping Ren contributed equally to this work.</p></fn></author-notes><pub-date pub-type="ppub"><day>20</day><month>7</month><year>2015</year></pub-date><volume>128</volume><issue>14</issue><fpage>1905</fpage><lpage>1909</lpage><history><date date-type="received"><day>11</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2015 Chinese Medical Journal</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>To evaluate whether serotonin (5-HT), 5-HT2A receptor (5-HT2AR), and 5-HT transporter (serotonin transporter [SERT]) are associated with different disease states of depression, myocardial infarction (MI) and MI co-exist with depression in Sprague-Dawley rats.</p></sec><sec id="st2"><title>Methods:</title><p>After established the animal model of four groups include control, depression, MI and MI with depression, we measured 5-HT, 5-HT2AR and SERT from serum and platelet lysate.</p></sec><sec id="st3"><title>Results:</title><p>The serum concentration of 5-HT in depression rats decreased significantly compared with the control group (303.25 &#x000b1; 9.99 vs. 352.98 &#x000b1; 13.73; <italic>P</italic> = 0.000), while that in MI group increased (381.78 &#x000b1; 14.17 vs. 352.98 &#x000b1; 13.73; <italic>P</italic> = 0.000). However, the depression + MI group had no change compared with control group (360.62 &#x000b1; 11.40 vs. 352.98 &#x000b1; 13.73; <italic>P</italic> = 0.036). The changes of the platelet concentration of 5-HT in the depression, MI, and depression + MI group were different from that of serum. The levels of 5-HT in above three groups were lower than that in the control group (380.40 &#x000b1; 17.90, 387.75 &#x000b1; 22.28, 246.40 &#x000b1; 18.99 vs. 500.29 &#x000b1; 20.91; <italic>P</italic> = 0.000). The platelet lysate concentration of 5-HT2AR increased in depression group, MI group, and depression + MI group compared with the control group (370.75 &#x000b1; 14.75, 393.47 &#x000b1; 15.73, 446.66 &#x000b1; 18.86 vs. 273.66 &#x000b1; 16.90; <italic>P</italic> = 0.000). The serum and platelet concentration of SERT in the depression group, MI group and depression + MI group were all increased compared with the control group (527.51 &#x000b1; 28.32, 602.02 &#x000b1; 23.32, 734.76 &#x000b1; 29.59 vs. 490.56 &#x000b1; 16.90; <italic>P</italic> = 0.047, <italic>P</italic> = 0.000, <italic>P</italic> = 0.000 in each and 906.38 &#x000b1; 51.84, 897.33 &#x000b1; 60.34, 1030.17 &#x000b1; 58.73 vs. 708.62 &#x000b1; 51.15; <italic>P</italic> = 0.000 in each).</p></sec><sec id="st4"><title>Conclusions:</title><p>The concentration of 5-HT2AR in platelet lysate and SERT in serum and platelet may be involved in the pathway of MI with depression. Further studies should examine whether elevated 5-HT2AR and SERT may contribute to the biomarker in MI patients with depression.</p></sec></abstract><kwd-group><kwd>5-HT</kwd><kwd>5-HT2A Receptor</kwd><kwd>Depression</kwd><kwd>Myocardial Infarction</kwd><kwd>Serotonin Transporter</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Major depression and coronary heart disease (CHD) are two most global burden diseases worldwide. The co-occurrence of these two disorders is common and associated with substantially increased morbidity and mortality. Recent epidemiological research has shown that major depression and CHD each independently increase risk for the other disorder. Although many plausible explanations have been proposed, the biological mechanisms linking depression and CHD remain unclear. Dysregulation of peripheral serotonin, common to both depression and CHD, may contribute to this association. Because of serotonin's dual effects promoting platelet aggregation and arterial vasoconstriction, serotoninergic signaling pathways are important in the etiology and pathogenesis of both major depression and vascular thrombosis.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><p>Serotonin is a vasoactive substance found in the brain, gut, and blood platelets. Alteration of the serotonin system associated with depressive disorders includes increased platelet aggregation, alteration in platelet serotonin uptake, decreased platelet serotonin transporter [SERT] sites, and increases in platelet serotonin binding density. In cardiac system, it exerts diverse cardio-physiologic effects, with 5-HT1 receptor mediating vasodilation and the 5-HT2 receptor mediating vasoconstriction.</p><p>All the 5-HT played an important role in the state of depression[<xref rid="ref2" ref-type="bibr">2</xref>] and acute coronary syndrome occurring during the process of development; one of the common disease mechanisms is platelet 5-HT and 5-HT receptor. However, there is no evidence to show which biological marker can be used to screen the co-occurrence of acute coronary syndrome and depression. So our study aimed to observe the changes of platelet 5-HT, 5-HT2A receptor (5-HT2AR) and SERT level in different disease states, which include normal, acute myocardial infarction (MI), depression, acute MI with depression.</p></sec><sec sec-type="methods" id="sec1-2"><title>M<sc>ETHODS</sc></title><sec id="sec2-1"><title>Animal model</title><p><bold>Control group</bold></p><p>Sprague-Dawley (SD) adult male rats (250 g <italic>n</italic> = 6).</p><p><bold>Depression group: The forced swim test</bold></p><p>Sprague-Dawley adult male rats (250 g <italic>n</italic> = 6) were submitted to a modified forced swim test (FST) similar to described by Porsolt <italic>et al.</italic>,[<xref rid="ref3" ref-type="bibr">3</xref>] except that the water was deeper. Briefly, each animal was placed in a cylinder (40 cm height, 20 cm diameter) containing 30 cm water maintained at 25&#x000b0;C. The modified FST with 30 cm water depth was used in order to avoid false immobility due to the capability of adult rats to rest on their tail touching the bottom of the cylinder when the lower volume, that is, 15 cm in the FST described by Porsolt <italic>et al.</italic>, is used.</p><p>After a pretest session of 15 cm, the rats were dried (under a warm air current), and 24 h later exposed again to the FST for 5 min, as described above.</p><p><bold>Myocardial infarction group: Myocardial infarction animal model</bold></p><p>According to surgical model of MI, the SD rats were anesthetized with ketamine (40 mg/kg) and xylazine (1 mg/kg) by intramuscular application, and then conduct surgical model of MI according to Akbay <italic>et al.</italic> previous described.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p><bold>Depression + myocardial infarction group: Depression with myocardial infarction animal model</bold></p><p>After recovered from MI surgery, the SD rat conducted FST.</p></sec><sec id="sec2-2"><title>Experiment material and regent preparation</title><p>
<list list-type="bullet"><list-item><p>Instruments and materials: Microplate reader capable of measuring absorbance at 450 nm, micropipette, pipette tips, distilled water or deionized water, filter paper</p></list-item><list-item><p>&#x000d7;30 wash solution: Dilute with distilled or deionized water 1:30.</p></list-item></list>
</p></sec><sec id="sec2-3"><title>Sample collection and storage</title><p>The blood samples were collected from the tail vein and placed into chilled tubes containing ethylenediaminetetraacetic acid. Whole blood was aliquoted and stored at &#x02212;70&#x000b0;C until time of assay. The blood was centrifuged within 30 min for 15 min at 200 <italic>&#x000d7;g</italic> at room temperature to obtain platelet-rich plasma (PRP) as described previously.[<xref rid="ref5" ref-type="bibr">5</xref>] Successively, PRP was aspirated and sonicated with three cycles of 10s on ice. In order to prepare isolated platelets, PRP was centrifuged for 10 min at 2100 <italic>&#x000d7;g</italic> at 4&#x000b0;C, and then prepared according to Rao <italic>et al.</italic>[<xref rid="ref5" ref-type="bibr">5</xref>]</p></sec><sec id="sec2-4"><title>ELISA method to detect 5-HT, 5-HT2A receptor, and serotonin transporter content</title><p>According to the instruction of ELISA kits of 5-HT, 5-HT2AR and SERT.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>Differences in characteristics between different groups were compared using tests for a continuous variable.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>R<sc>ESULTS</sc></title><p><xref ref-type="table" rid="T1">Table 1</xref> indicates the concentration of 5-HT, 5-HT2AR, and SERT in serum and platelet lysate in different groups (control group, depression group, MI group, depression + MI group). The serum concentration of 5-HT in depression rats decreased significantly compared with the control group (303.25 &#x000b1; 9.99 vs. 352.98 &#x000b1; 13.73), there were significant differences (<italic>P</italic> = 0.000), while in MI group increased (381.78 &#x000b1; 14.17 vs. 352.98 &#x000b1; 13.73; <italic>P</italic> = 0.000). However, the depression + MI group had no change compared with control group (360.62 &#x000b1; 11.40 vs. 352.98 &#x000b1; 13.73; <italic>P</italic> = 0.036), had significant changes compared with depression group and MI group (<italic>P</italic> = 0.000, <italic>P</italic> = 0.009).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Concentration of 5-HT, 5-HT2AR, and SERT in serum and platelet lysate in different group (control group, depression group, MI group, depression + MI group)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1"><italic>n</italic></th><th align="center" rowspan="1" colspan="1">Mean &#x000b1; SD</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Serum 5-HT</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Control</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">352.98 &#x000b1; 13.73</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">303.25 &#x000b1; 9.99</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">381.78 &#x000b1; 14.17</td><td align="center" rowspan="1" colspan="1">0.001*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02020;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression + MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">360.62 &#x000b1; 11.40</td><td align="center" rowspan="1" colspan="1">0.326*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02020;</sup></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.009<sup>&#x02021;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet 5-HT</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Control</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">500.29 &#x000b1; 20.91</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">380.40 &#x000b1; 17.90</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">387.75 &#x000b1; 22.28</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.571<sup>&#x02020;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression+MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">246.40 &#x000b1; 18.99</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02020;</sup></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02021;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet 5-HT2AR</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Control</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">273.66 &#x000b1; 16.90</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">370.75 &#x000b1; 14.75</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">393.47 &#x000b1; 15.73</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.037<sup>&#x02020;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression+MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">446.66 &#x000b1; 18.86</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02020;</sup></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02021;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Serum SERT</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Control</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">490.56 &#x000b1; 28.50</td><td align="center" rowspan="1" colspan="1">0.047*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">527.51 &#x000b1; 28.32</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">602.02 &#x000b1; 23.32</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02020;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression + MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">734.76 &#x000b1; 29.59</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02020;</sup></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.000<sup>&#x02021;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet SERT</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Control</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">708.62 &#x000b1; 51.15</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">906.38 &#x000b1; 51.84</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">897.33 &#x000b1; 60.34</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.773<sup>&#x02020;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Depression + MI</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1030.17 &#x000b1; 58.73</td><td align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.001<sup>&#x02020;</sup></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.001<sup>&#x02021;</sup></td></tr></tbody></table><table-wrap-foot><fn><p>*Contrast to control group; &#x02020;Contrast to depression group; &#x02021;Contrast to MI group. MI: Myocardial infarction; SD: Standard deviation; SERT: Serotonin transporter; 5-HT2AR: 5-HT2A receptor.</p></fn></table-wrap-foot></table-wrap><p>The platelet lysate concentration of 5-HT in the depression group, MI group, and depression + MI group were lower than that in the control group (380.40 &#x000b1; 17.90, 387.75 &#x000b1; 22.28, 246.40 &#x000b1; 18.99 vs. 500.29 &#x000b1; 20.91), and all had significant difference (<italic>P</italic> = 0.000). There was no significant difference between depression group and MI group (387.75 &#x000b1; 22.28 vs. 380.40&#x000b1; +17.90; <italic>P</italic> = 0.571), but two groups had significant difference compared to depression + MI group (380.40 &#x000b1; 17.90, 387.75 &#x000b1; 22.28 vs. 246.40 &#x000b1; 18.99; <italic>P</italic> = 0.000) [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Concentration of 5-HT in serum and platelet lysate.</p></caption><graphic xlink:href="CMJ-128-1905-g001"/></fig><p>The platelet lysate concentration of 5-HT2AR increased in depression group, MI group and depression + MI group compared with the control group (370.75 &#x000b1; 14.75, 393.47 &#x000b1; 15.73, 446.66 &#x000b1; 18.86 vs. 273.66 &#x000b1; 16.90), and all had significant difference (<italic>P</italic> = 0.000). There is significant difference between the MI group and depression group (393.47 &#x000b1; 15.73 vs. 370.75 &#x000b1; 14.75; <italic>P</italic> = 0.037), Concentration in depression + MI group increased compared with depression group and the MI group, there was statistical difference (446.66 &#x000b1; 18.86 vs. 370.75 &#x000b1; 14.75, 393.47 &#x000b1; 15.73; <italic>P</italic> = 0.000) [<xref ref-type="fig" rid="F2">Figure 2</xref>].</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Concentration of 5-HT2A receptor in platelet lysate.</p></caption><graphic xlink:href="CMJ-128-1905-g002"/></fig><p>The serum concentration of SERT in the depression group, MI group and depression + MI group were increased compared with the control group (527.51 &#x000b1; 28.32, 602.02 &#x000b1; 23.32, 734.76 &#x000b1; 29.59 vs. 490.56 &#x000b1; 16.90), and had obvious statistical difference (<italic>P</italic> = 0.047, <italic>P</italic> = 0.000, <italic>P</italic> = 0.000). The SERT concentration in MI group increased compared with depression group, there was statistical difference (602.02 &#x000b1; 23.32 vs. 527.51 &#x000b1; 28.32; <italic>P</italic> = 0.000). The SERT concentration in depression + MI group increased than that of depression group and MI group, there were statistical differences (734.76 &#x000b1; 29.59 vs. 527.51 &#x000b1; 28.32, 602.02 &#x000b1; 23.32; <italic>P</italic> = 0.000) [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Concentration of serotonin transporter in serum and platelet lysate.</p></caption><graphic xlink:href="CMJ-128-1905-g003"/></fig><p>The platelet lysate concentration of SERT in the depression group, MI group, and depression + MI group was increased compared with the control group (906.38 &#x000b1; 51.84, 897.33 &#x000b1; 60.34, 1030.17 &#x000b1; 58.73 vs. 708.62 &#x000b1; 51.15), and had obvious statistical difference (<italic>P</italic> = 0.000). There were no changes between MI group and depression group (897.33 &#x000b1; 60.34, vs. 906.38 &#x000b1; 51.84; <italic>P</italic> = 0.773). The concentration in depression + MI group increased compared with depression group and the MI group, there were significant differences (1030.17 &#x000b1; 58.73 vs. and 906.38 &#x000b1; 51.84, 897.33 &#x000b1; 60.34; <italic>P</italic> = 0.001, <italic>P</italic> = 0.001) [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p></sec><sec sec-type="discussion" id="sec1-4"><title>D<sc>ISCUSSION</sc></title><p>In order to evaluate whether depression is associated with whole blood serotonin (WBS) in outpatients with stable CHD. The data from the Heart and Soul study showed that in the sample of patients with stable CHD, current major depression was independently associated with high mean WBS levels.[<xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Schins <italic>et al.</italic> also reported the association of depression with elevated WBS in a small case-control study of 25 depressed and 21 nondepressed MI patients.[<xref rid="ref7" ref-type="bibr">7</xref>] Vikenes <italic>et al.</italic> reported that high levels WBS were significantly associated with CHD in an angiography sample, particularly in younger age groups.[<xref rid="ref8" ref-type="bibr">8</xref>] However, it should be noted that there were some inconsistent results of the studies that have demonstrated an association of depression with lower peripheral serotonin levels,[<xref rid="ref9" ref-type="bibr">9</xref>] which consistent to our study. Our study showed that concentration of peripheral 5-HT decrease in depression group, increase in MI group and no change in depression + MI group. Part reasons of the inconsistent results dependent on the method of animal model.</p><p>However, many of these studies measured serum or plasma serotonin, and because most serotonin is in platelets, the extent of which WBS correlated with serum or plasma serotonin is unclear. Our animal study also showed the different change of serotonin in plasma and platelet in different groups. And all of the above studies came from patients.</p><p>Low levels of central serotonin have been related to the state of depression, and 5-HT is the major target of newer antidepressant drugs, such as selective serotonin re-uptake inhibitors. Neurons and platelets display structural and functional similarities, so that the latter have been proposed as a peripheral model of central functions. In particular, in blood more than 99% of 5-HT is contained in platelet, so that one could consider changes in 5-HT levels in platelets as a mirror of changes in central 5-HT.[<xref rid="ref10" ref-type="bibr">10</xref>]</p><p>The availability of 5-HT is strictly limited by a selective, active re-uptake mechanism performed by a specific protein, the 5-HT transporter (SERT), which plays the significant role of terminating the activity of the neurotransmitter. Besides of the central nervous system, the SERT has been found in intestinal epithelial cells, in blood platelet and blood lymphocytes. The involvement of SERT in clinical depression and anxiety has received enormous attention from discovery of the significance of SERT polymorphisms on human behavior.[<xref rid="ref11" ref-type="bibr">11</xref>] SERT on platelets is the primary mechanism for 5-HT uptake from blood plasma. Therefore, the regulation of the transporter's activity represents a key mechanism to stabilize the concentration of plasma 5-HT. Specially, in platelets, plasma membrane SERT levels and platelet 5-HT uptake initially rise as plasma 5-HT levels are increased but then fall below normal as the plasma 5-HT level continues to rise. Therefore, we propose that elevated plasma 5-HT limits its own uptake in platelets down-regulating SERT as well as modifying the characteristics of SERT partners in the membrane trafficking pathway.[<xref rid="ref12" ref-type="bibr">12</xref>]</p><p>Increased 5-HT2AR density has been reported in depressed patients.[<xref rid="ref13" ref-type="bibr">13</xref>] Patients with depressive disorder show signs of hyperactive platelet 5-HT2AR signal transduction system as measured by increased platelet calcium mobilization after stimulation of platelets with serotonin.[<xref rid="ref14" ref-type="bibr">14</xref>] The 5-HT2AR is linked to the platelet phosphoinositide-signaling system and is responsible for activating 5-HT-mediated platelet aggregation. Because there is direct correlation between the number of platelet 5-HT2ARs and the magnitude of the aggregation response to 5-HT, the increase in 5-HT-mediated platelet reactivity may be a consequence of 5-HT2AR up-regulation. This is supported by several studies indicating that depression is associated with an up-regulation of platelet 5-HTA receptor, and an increased response of the platelet phosphoinositide-signaling system to 5-HT. Our study showed that up-regulation of 5-HT2ARs in depression group, MI group, as well as in co-occurrence group. The MI comorbidity with depression rats had a higher level of 5-HT2AR.</p><p>There are many conflicting results from different studies, such as increased serotonin response, increased platelet serotonin receptor density, decreased SERT binding, and decreased platelet serotonin levels in individuals with depression. While the studies to date are not definitive, and the mechanisms responsible unknown, the observation of increased platelet 5-HT2AR and platelet and serum SERT in MI with depression SD rats is a remarkably consistent observation. Thus, measurement of platelet 5-HT2AR and SERT may provide a &#x0201c;window to the brain&#x0201d; and potentially provide a useful, easily available laboratory marker to aid in the diagnosis of depression in MI.</p><p>In addition to platelet serotonin specific pathways, other platelet pathways that shown significant changes in depressed individuals include blunting the platelet adenosine response, increased platelet thrombin response, as well as decreased platelet brain-derived neurotrophic factor.[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] Hence, the direction of future research in platelet functional changes in depression and CHD[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] showed continuous to focus on serotonin specific pathways with emphasis on potential mechanisms of specific pathway changes.</p></sec></body><back><fn-group><fn fn-type="edited-by"><p><bold>Edited by:</bold> Yi Cui</p></fn><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil.</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivier</surname><given-names>B</given-names></name></person-group><article-title>Serotonin: A never-ending story</article-title><source>Eur J Pharmacol</source><year>2015</year><volume>753</volume><fpage>2</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">25446560</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>JP</given-names></name><name><surname>Medvedev</surname><given-names>IO</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name></person-group><article-title>The 5-HT deficiency theory of depression: Perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2012</year><volume>367</volume><fpage>2444</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">22826344</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porsolt</surname><given-names>RD</given-names></name><name><surname>Le Pichon</surname><given-names>M</given-names></name><name><surname>Jalfre</surname><given-names>M</given-names></name></person-group><article-title>Depression: A new animal model sensitive to antidepressant treatments</article-title><source>Nature</source><year>1977</year><volume>266</volume><fpage>730</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">559941</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbay</surname><given-names>E</given-names></name><name><surname>Onur</surname><given-names>MA</given-names></name></person-group><article-title>A new modified myocardial infarction animal model</article-title><source>J Cardiovasc Surg</source><year>2013</year><volume>1</volume><fpage>69</fpage><lpage>71</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>ML</given-names></name><name><surname>Hawellek</surname><given-names>B</given-names></name><name><surname>Papassotiropoulos</surname><given-names>A</given-names></name><name><surname>Deister</surname><given-names>A</given-names></name><name><surname>Frahnert</surname><given-names>C</given-names></name></person-group><article-title>Upregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patients</article-title><source>Neuropsychobiology</source><year>1998</year><volume>38</volume><fpage>84</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9732208</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulsin</surname><given-names>LR</given-names></name><name><surname>Musselman</surname><given-names>D</given-names></name><name><surname>Otte</surname><given-names>C</given-names></name><name><surname>Bruce</surname><given-names>E</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Whooley</surname><given-names>MA</given-names></name></person-group><article-title>Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study</article-title><source>Psychosom Med</source><year>2009</year><volume>71</volume><fpage>260</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19297311</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schins</surname><given-names>A</given-names></name><name><surname>Hamuly&#x000e1;k</surname><given-names>K</given-names></name><name><surname>Scharp&#x000e9;</surname><given-names>S</given-names></name><name><surname>Lousberg</surname><given-names>R</given-names></name><name><surname>Van Melle</surname><given-names>J</given-names></name><name><surname>Crijns</surname><given-names>H</given-names></name><etal/></person-group><article-title>Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients</article-title><source>Life Sci</source><year>2004</year><volume>76</volume><fpage>637</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15567189</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vikenes</surname><given-names>K</given-names></name><name><surname>Farstad</surname><given-names>M</given-names></name><name><surname>Nordrehaug</surname><given-names>JE</given-names></name></person-group><article-title>Serotonin is associated with coronary artery disease and cardiac events</article-title><source>Circulation</source><year>1999</year><volume>100</volume><fpage>483</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10430761</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleare</surname><given-names>AJ</given-names></name></person-group><article-title>Reduced whole blood serotonin in major depression</article-title><source>Depress Anxiety</source><year>1997</year><volume>5</volume><fpage>108</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9262942</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>M</given-names></name><name><surname>Moser</surname><given-names>C</given-names></name><name><surname>Lazzarini</surname><given-names>C</given-names></name><name><surname>Vecchiato</surname><given-names>E</given-names></name><name><surname>Crespi</surname><given-names>F</given-names></name></person-group><article-title>Forced swimming test and fluoxetine treatment: <italic>In vivo</italic> evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes</article-title><source>Exp Brain Res</source><year>2002</year><volume>143</volume><fpage>191</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11880895</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>DL</given-names></name><name><surname>Fox</surname><given-names>MA</given-names></name><name><surname>Timpano</surname><given-names>KR</given-names></name><name><surname>Moya</surname><given-names>PR</given-names></name><name><surname>Ren-Patterson</surname><given-names>R</given-names></name><name><surname>Andrews</surname><given-names>AM</given-names></name><etal/></person-group><article-title>How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems</article-title><source>Neuropharmacology</source><year>2008</year><volume>55</volume><fpage>932</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">18824000</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercado</surname><given-names>CP</given-names></name><name><surname>Kilic</surname><given-names>F</given-names></name></person-group><article-title>Molecular mechanisms of SERT in platelets: Regulation of plasma serotonin levels</article-title><source>Mol Interv</source><year>2010</year><volume>10</volume><fpage>231</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">20729489</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelton</surname><given-names>RC</given-names></name><name><surname>Sanders-Bush</surname><given-names>E</given-names></name><name><surname>Manier</surname><given-names>DH</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group><article-title>Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A</article-title><source>Neuroscience</source><year>2009</year><volume>158</volume><fpage>1406</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">19111907</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schins</surname><given-names>A</given-names></name><name><surname>Honig</surname><given-names>A</given-names></name><name><surname>Crijns</surname><given-names>H</given-names></name><name><surname>Baur</surname><given-names>L</given-names></name><name><surname>Hamuly&#x000e1;k</surname><given-names>K</given-names></name></person-group><article-title>Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?</article-title><source>Psychosom Med</source><year>2003</year><volume>65</volume><fpage>729</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">14508013</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>MS</given-names></name></person-group><article-title>Platelets and depression in cardiovascular disease: A brief review of the current literature</article-title><source>World J Psychiatry</source><year>2012</year><volume>2</volume><fpage>114</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">24175177</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleis</surname><given-names>JR</given-names></name><name><surname>Ward</surname><given-names>BW</given-names></name><name><surname>Lucas</surname><given-names>JW</given-names></name></person-group><article-title>Summary health statistics for U.S. adults: National Health Interview Survey, 2009</article-title><source>Vital Health Stat 10</source><year>2010</year><volume>249</volume><fpage>1</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">21905346</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name></person-group><article-title>Possible role of platelet GluR1 receptors in comorbid depression and cardiovascular disease</article-title><source>Cardiovasc Psychiatry Neurol</source><year>2009</year><volume>2009</volume><fpage>424728</fpage><pub-id pub-id-type="pmid">20029621</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canan</surname><given-names>F</given-names></name><name><surname>Dikici</surname><given-names>S</given-names></name><name><surname>Kutlucan</surname><given-names>A</given-names></name><name><surname>Celbek</surname><given-names>G</given-names></name><name><surname>Coskun</surname><given-names>H</given-names></name><name><surname>Gungor</surname><given-names>A</given-names></name><etal/></person-group><article-title>Association of mean platelet volume with DSM-IV major depression in a large community-based population: The MELEN study</article-title><source>J Psychiatr Res</source><year>2012</year><volume>46</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">22154758</pub-id></element-citation></ref></ref-list></back></article>